Researchers

Salmaan Kanji

BSc Pharm, PharmD

Associate Scientist, Acute Care Research

Ottawa Hospital Research Institute

Clinical Pharmacy Specialist-Critical Care, Department of Pharmacy

The Ottawa Hospital

Assistant Professor, Faculty of Medicine

University of Ottawa

Adjunct Professor, Faculty of Pharmacy

University of Montreal

Contact

skanji@ottawahospital.on.ca

613 737-8899 ext 78159

ORCID 0000-0003-0594-0360

Bio

Dr. Kanji obtained his Bachelor of Science degree in Pharmacy from the University of Alberta in 1997 after which he completed a pharmacy residency at the Ottawa Hospital in 1998. He then received his Doctor of Pharmacy degree from Wayne State University (Detroit, MI) in 2000 followed by a two-year post-doctoral fellowship in Critical Care Medicine completed in 2002. Dr. Kanji has been a Clinical Pharmacy Specialist in the ICU of the Ottawa Hospital since 2002 and an Associate Scientist with the Ottawa Hospital Research Institute since 2003.

Research Goals and Interests

Critical Care Pharmacotherapy with a focus on the management of Atrial Fibrillation in critically ill patients. Other research interests include toxicology, glycemic control, and the management of severe sepsis.

News

Publications

Risk Factors for Patient-Important Upper Gastrointestinal Bleeding

2025-09-01 Go to publication

Environmentally sustainable opportunities for health systems: Metered-dose inhaler prescribing, dispensing, use and waste at a tertiary academic centre

2024-11-01 Go to publication

Antimicrobial therapeutic drug monitoring in critically ill adult patients – An international perspective on access, utilisation, and barriers

2024-08-01 Go to publication

Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy

2023-11-01 Go to publication

Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermittent renal replacement therapy: A systematic review

2023-11-01 Go to publication
View More on ORCiD

07/2014-07/2016
Antimicrobial pharmacokinetics in critically ill adults during sustained low efficiency dialysis
Principal: S. Kanji
Funding: The Kidney Foundation of Canada
Funds awarded: $100,000
Years 2

06/2014-06/2015
Implementation of evidenced-based guidelines for the management of pain, agitation and delirium to facilitate early mobilization in the Intensive Care Unit: A Quality Improvement Project
Principal: E. Rosenberg & G. Wolff
Role: Co-investigator
Funding: Department of Medicine (PQ&SC)
Funds awarded: $30,160
Years 1

01/2014-12/2014
Validation of a Pain Assessment Tool (CPOT) in Critically Ill Patients with Delirium
Principal: S. Kanji
Funding: CSHP Foundation, Research Grant
Funds awarded: $8,000
Years 1

01/2014-12/2014
Antimicrobial Pharmacokinetics in Critically Ill Adults during SustainedLow Efficiency Dialysis (SLED)
Principal: R. Patel
Role: Co-investigator
Funding: Ottawa Hospital, Department of Medicine
Developmental Research Grant
Funds awarded: $12,122
Years 1

03/2013-02/2014
The risk of elevated prolactin levels in pediatric patients exposed to risperidone and other antipsychotics for the treatment of schizophrenia and otherschizophrenia spectrum disorders: a network meta-analysis
Principal: D. Moher
Role: Co-investigator
Funding:Canadian Institutes of Health Research
Funds awarded: $96,943
Years 1

03/2013-02/2014
Adding clarity to uncertainty in the study of drug safety
Principal: B. Hutton
Role: Co-investigator
Funding:Canadian Institutes of Health Research
Program: Operating Grant - PA: Drug Safety and Effectiveness (bridge funding) from the Drug Safety and Effectiveness Network (DSEN)
Funding awarded: $100,000
Years 1

02/2013-02/2015
Optimal VAsopressorTItratiON (OVATION) Pilot Randomized controlled Trial
Principal: F. Lamontange
Role: Co-applicant
Funding: Canadian Institutes of Health Research
Funding awarded: $379,078
Years 2

Related Research at The Ottawa Hospital